TP53 and KRAS2 mutations in plasma DNA of healthy subjects and subsequent cancer occurrence: a prospective study.

TP53 and KRAS2 mutations in plasma DNA of healthy subjects and subsequent cancer occurrence: a prospective study.

Show other versions (1)

In cancer patients, plasma often contains mutant DNA released by cancer cells. We have assessed the significance of plasma DNA mutations for subsequent cancer development in healthy subjects in a large longitudinal prospective study. The European Prospective Investigation into Cancer and Nutrition s...

Full description

Bibliographic Details
Main Authors: Gormally, E, Vineis, P, Matullo, G, Veglia, F, Caboux, E, Le Roux, E, Peluso, M, Garte, S, Guarrera, S, Munnia, A, Airoldi, L, Autrup, H, Malaveille, C, Dunning, A, Overvad, K, Tjønneland, A, Lund, E, Clavel-Chapelon, F, Boeing, H, Trichopoulou, A, Palli, D, Krogh, V, Tumino, R, Panico, S, Bueno-de-Mesquita, H
Format: Journal article
Language:English
Published: 2006

Similar Items

Similar Items